Exosomes-coated bcl-2 siRNA inhibits the growth of digestive system tumors both in vitro and in vivo.

International Journal of Biological Macromolecules
Hongyu TaoXiukun Lin

Abstract

The therapeutic application of small interfering RNA is limited by the lack of an effective delivery system to tumors. In the present study, an efficient approach to deliver siRNA to cancer cells using exosome system was developed. Exosomes were isolated from bovine milk and exosomes-coated bcl-2 siRNA (exosiBcl-2) was synthesized using ultrasonic approach. The anticancer effect of exsosiBcl-2 was studied by Confocal microscopy, flow cytometry, scratch wound healing and Transwell experiments, RT-qPCR and Western blot approaches, etc. Xenograft nude mice tumor model was performed to check the antitumor activity of exosiBcl-2 in vivo. ExosiBcl-2 can cross the cell membrane efficiently and inhibit the growth of cancer cells. ExosiBcl-2 treatment led to apoptosis and dramatic inhibition of migration and invasion of cancer cells via downregulating metastatic related genes. In vivo study revealed that exosiBcl-2 inhibited the tumor growth significantly in nude mice. ExosiBcl-2 has potential to be developed as a novel anticancer agent.

References

Feb 1, 1992·Seminars in Oncology Nursing·L A Dudjak
Dec 9, 2004·Journal of Neurochemistry·Wolfgang WickMichael Weller
Jul 5, 2005·Cancer Research·Jihyung ChoiKyoungsook Park
Dec 19, 2006·Nature Chemical Biology·Niraj H Tolia, Leemor Joshua-Tor
Jul 17, 2007·Cell·Stefan Ludwig AmeresRenée Schroeder
Mar 23, 2011·Nature Biotechnology·Lydia Alvarez-ErvitiMatthew J A Wood
Oct 4, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shin-ichiro OhnoMasahiko Kuroda
Aug 3, 2013·Neoplasia : an International Journal for Oncology Research·Wei MuMargot Zöller
Feb 15, 2014·Biochemical and Biophysical Research Communications·Keisuke ShimboMitsuo Ochi
Jun 2, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Jian-Jun WangGuang-Xin Li
Nov 17, 2015·Nature Reviews. Drug Discovery·Jonathan E Zuckerman, Mark E Davis
Nov 26, 2015·Cancer Letters·Radha MunagalaRamesh C Gupta
Nov 25, 2016·American Journal of Physiology. Lung Cellular and Molecular Physiology·Duo ZhangYang Jin
Mar 17, 2017·Nanomedicine : Nanotechnology, Biology, and Medicine·Ashish K AgrawalRamesh C Gupta
Sep 30, 2017·Journal of Gastroenterology and Hepatology·Kwang-Pil KoKeun-Young Yoo
May 22, 2018·International Journal of Biological Macromolecules·Shweta JainAnkur Vaidya
Jun 30, 2018·Recent Patents on Anti-cancer Drug Discovery·Shuonan SuXiukun Lin
Jan 1, 2018·Cell Death and Differentiation·Jerry M Adams, Suzanne Cory

❮ Previous
Next ❯

Citations

Oct 8, 2020·International Journal of Molecular Sciences·Ki-Uk KimHyeyoung Min
Mar 23, 2021·Advanced Drug Delivery Reviews·Michaela Schulz-Siegmund, Achim Aigner
May 21, 2021·Advanced Drug Delivery Reviews·Pol Escudé Martinez de CastillaJiong-Wei Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.